Deferiprone
ATC V03AC02 · 9 markets · 46 records
US 10 records · 3 strengths
GB 10 records · 5 strengths
- 500 mgtabletFERRIPROX__no_trade__
- 1,000 mgtabletFERRIPROX
- 100 mgliquidFerriprox 100mg/ml oral solution
- 400 mgcapsuleNo trade name
- 400 mg/5 mLliquidNo trade name
AU 8 records · 5 strengths
- 500 mgtabletFERRIPROXFERRIPROX deferiprone 25g/250mL oral solution bottle
- 1,000 mgtabletFERRIPROXFERRIPROX deferiprone 25g/250mL oral solution bottle
- 100 mg/1 mLliquidFERRIPROX
- 100 mg/mLliquidFERRIPROX deferiprone 25g/250mL oral solution bottle
Records without a stated strength · 1 FERRIPROX
HK 6 records · 1 strengths
Records without a stated strength · 1 BEFEPROX FILM-COATED TABLETS 1000MG、FERRIPROX、Ferriprox 100mg/ml oral solution、FERRIPROX MR MODIFIED-RELEASE TABLETS 1000MG
CA 5 records · 4 strengths
SG 2 records · 2 strengths
- 500 mgtabletFERRIPROX
- 100 g/LliquidFerriprox 100mg/ml oral solution
CN 2 records · 2 strengths
- 500 mgtablet奥贝安可去铁酮
- 100 mg/1 mLliquidManufacturer: ChiesiFarmaceuticiS.p.A.
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Deferiprone Lipomed、FERRIPROX
TW 1 records · 1 strengths
- 500 mgcapsuleKELFER CAPSULES 500MG康鐵寧 膠囊500公絲
| Strength / form / release | US | GB | CA | AU | SG | CN | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 500 mgRecorded as: 0.5 g tablet | No trade name | No trade name FERRIPROX | FERRIPROX | FERRIPROX FERRIPROX deferiprone 25g/250mL oral solution bottle | FERRIPROX | 奥贝安可去铁酮 | |||
| 1,000 mgRecorded as: 1 g tablet | No trade name FERRIPROX | FERRIPROX | FERRIPROX TARO-DEFERIPRONE | FERRIPROX FERRIPROX deferiprone 25g/250mL oral solution bottle | |||||
| 100 mg liquid | FERRIPROX | Ferriprox 100mg/ml oral solution | FERRIPROX | ||||||
| 500 mg capsule | KELFER CAPSULES 500MG 康鐵寧 膠囊500公絲 | ||||||||
| 100 mg/1 mL liquid | FERRIPROX | Manufacturer: ChiesiFarmaceuticiS.p.A. | |||||||
| 1,000 mg tablet · extended-release | FERRIPROX | ||||||||
| 400 mg capsule | No trade name | ||||||||
| 400 mg/5 mL liquid | No trade name | ||||||||
| 100 g/L liquid | Ferriprox 100mg/ml oral solution | ||||||||
| 100 mg/mL liquid | FERRIPROX deferiprone 25g/250mL oral solution bottle | ||||||||
unknown | FERRIPROX | BEFEPROX FILM-COATED TABLETS 1000MG FERRIPROX Ferriprox 100mg/ml oral solution+1FERRIPROX MR MODIFIED-RELEASE TABLETS 1000MG | Deferiprone Lipomed FERRIPROX |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA · SG · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · SG · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · SG · TW 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 CA · SG · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.